I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
settimana scorsa
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
settimana scorsa
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
2 settimane fa
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
2 settimane fa
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
3 mesi fa
This too (and yh I DO wish I did this in CFD lol)
GGGGM
3 mesi fa
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
3 mesi fa
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
3 mesi fa
What do we think
At a loss now, watching a bit
GGGGM
3 mesi fa
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
3 mesi fa
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
3 mesi fa
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
3 mesi fa
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Questa pagina potrebbe includere contenuti generati dalla comunità, di cui Trading 212 non è responsabile. Svolgi sempre le tue ricerche. Trading 212 fornisce un servizio di sola esecuzione e non offre consigli di investimento o gestione del portafoglio.
Compra e vendi Capricor Therapeutics Inc +0,06 $ (0,8%) e oltre 13.000 azioni ed ETF globali
Scarica l'app
Apri account
Potrebbero essere applicate ulteriori commissioni. Visualizza i nostri termini e commissioni.
Compra azioni immediatamente
Scegli l'azienda che preferisci
Seleziona quanto investire
Ottieni le tue azioni in un attimo
Creare ricchezza è un'abitudine. Automatizzala con un pie.
Investi in pies preimpostati o crea il tuo scegliendo tra migliaia di azioni ed ETF.
Scopri di più
Scopri di più
Guarda il video
Arriva a possedere perfino le azioni più costose come quelle di Google, Amazon e Apple
Guarda il video
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Borsa di Londra
Euronext Lisbon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Borsa di Londra
Euronext Lisbon
Vedi tutti gli strumenti di trading
Assistenza 24/7
Tempo di risposta medio di 29 secondi
Inizia subito a creare un patrimonio
Unisciti a oltre 5 milioni di utenti
Scarica l'app
Apri account
Scarica l'app per dispositivi mobili
Tutte le statistiche presentate sono globali. Il numero di clienti rappresenta gli Accounts finanziati.
Eccellente
Valutato 4,6 / 5 in base a 108.764 recensioni su
Trustpilot
Valutato 4,6 / 5 in base a 108.764 recensioni su
Trustpilot
Invitato
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Invitato
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Invitato
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Invitato
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Invitato
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Invitato
How you rate the app
This app is so easy to use and safe really love it.
Invitato
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Invitato
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Invitato
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Invitato
Very good and informative always stay…
Very good and informative always stay on track with your investments
Invitato
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Invitato
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Invitato
Very easy app to register and use
Very easy app to register and use! Really pleased.
Invitato
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Invitato
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Invitato
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Invitato
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Invitato
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Invitato
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Invitato
Reliable
Reliable, Secure. Using it for past 3 years
Ecco alcune delle recensioni positive da parte dei clienti.
I nostri premi
Domande frequenti
Qual è il prezzo dell’azione Capricor Therapeutics?
Il prezzo attuale di Capricor Therapeutics è 7,59 $.
Qual è il massimo a 52 settimane di Capricor Therapeutics?
Il massimo a 52 settimane per Capricor Therapeutics è 40,37 $.
Qual è il minimo a 52 settimane di Capricor Therapeutics?
Il minimo a 52 settimane per Capricor Therapeutics è 2,96 $.
Qual è l’andamento settimanale di Capricor Therapeutics?
Nell’ultima settimana, il prezzo di Capricor Therapeutics è cambiato di -20,36%.
Qual è la performance mensile di Capricor Therapeutics?
Nell’ultimo mese, il prezzo di Capricor Therapeutics è cambiato di 14,14%.
Qual è la performance a 3 mesi di Capricor Therapeutics?
Negli ultimi tre mesi, il prezzo di Capricor Therapeutics è cambiato di -4,89%.
Qual è la performance a 6 mesi di Capricor Therapeutics?
Negli ultimi sei mesi, il prezzo di Capricor Therapeutics è cambiato di -71,81%.
Qual è il rendimento annuale di Capricor Therapeutics?
Nel corso dell’ultimo anno, il prezzo di Capricor Therapeutics è cambiato di 31,54%.